Loading…
Loading…
in atopic derm, at least from our data, it looks like things are starting to flatten out a little bit
I'm wondering if you could maybe square that dynamic with some of the aversion to M&A
Sanofi's commentary yesterday about taking potential for taking the runway out well beyond the current thinking
can you talk about how that clinic inventory policies have evolved over time and especially how private equity